A pilot study on platelet response to aspirin with whole blood platelet aggregation methods in stable coronary artery disease patients
Aspirin is an anti-platelet agent used to prevent thrombo-embolic complications related to coronary artery disease. It is currently the most cost effective drug for the secondary prevention of coronary artery disease, but treatment failures are relatively common. The tenn aspirin resistance has b...
Main Author: | Sanada, Abu Bakar |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2008
|
Subjects: | |
Online Access: | http://eprints.usm.my/52398/1/DR.%20ROHANA%20BINTI%20ABDUL%20RASHID%20-%2024%20pages.pdf |
Similar Items
-
The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing
by: Mostafa, Arwa Mohamed Amin
Published: (2016) -
Effect of red blood cells on platelet aggregation
by: Karniadakis, George E., et al.
Published: (2010) -
Prognostic significance of arterial stiffness and osteoprotegerin in patients with stable coronary artery disease
by: Siasos, Gerasimos, et al.
Published: (2022) -
Efek aspirin dosis rendah (30 mg) terhadap agregasi platelet pada perokok
by: , UZER, Fachry, et al.
Published: (1996) -
Efek aspirin dosis rendah (30 mg) terhadap agregasi platelet pada perokok
by: , UZER, Fachry, et al.
Published: (1996)